Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 03.08.2026 GMAY.LN IE000P0FL8E3 1,400,002.00 USD  56,490,547.76   40.350  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 03.08.2026 MISL.LN IE000NVDQXE1 4,500,002.00 USD 156,906,051.55   34.868  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Space Economy UCITS ETF 03.08.2026 FSPC.LN IE000ANMCD25   50,002.00 USD   1,032,187.46   20.643  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 03.08.2026 CHPS.LN IE000KXTLDE2  775,002.00 USD  35,967,062.93   46.409  ...

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment Company with Variable Capital (société d'investissement à capital variable) Registered office: 17, Boulevard de Kockelscheuer, L-1821 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) Important Notice Dividend Announcement 4 August 2026 The Board of Directors wishes to inform the Shareholders that a dividend per share for certain Share Classes and Sub-Funds will be paid, as set out below. Please note the following dates which apply to all...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 03.08.2026 QSEP.LN IE000FQ808R5  350,002.00 USD   8,641,980.41   24.691  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 03.08.2026 MMAR.LN IE0002PPCMH6   50,002.00 USD   1,338,164.90   26.762  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 03.08.2026 RCTR.LN IE000J5PESP7 2,500,002.00 USD  44,473,334.56   17.789  ...

NEWTON, Mass.--(BUSINESS WIRE)--Satellite Biosciences, Inc. (Satellite Bio), a clinical-stage biotechnology company developing off-the-shelf liver therapies designed to restore liver function in patients with severe liver diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SB-101, an investigational medicine for the treatment of urea cycle disorders (UCDs). SB-101 is a first-in-class, off-the-shelf liver cell...

NEW YORK--(BUSINESS WIRE)--American Express Global Business Travel Reports Strong Q2 2026 Financial Results...